Haemonetics
175 hedge funds and large institutions have $1.95B invested in Haemonetics in 2014 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 67 increasing their positions, 64 reducing their positions, and 39 closing their positions.
9% more capital invested
Capital invested by funds: $1.78B → $1.95B (+$165M)
1.72% more ownership
Funds ownership: 105.42% → 107.15% (+1.7%)
5% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 64
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 192 → 175 (-17)
44% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 39
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $78K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$45M |
| 2 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
+$43.6M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$24.4M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$20.5M |
| 5 |
ICOM
Investment Counselors of Maryland
Baltimore,
Maryland
|
+$15.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$37.1M |
| 2 |
CI Investments Inc
Toronto,
Ontario, Canada
|
-$29.8M |
| 3 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$23.1M |
| 4 |
EIP
Epoch Investment Partners
New York
|
-$17.9M |
| 5 |
PP
Prudential plc
London, England,
United Kingdom
|
-$12.5M |
HAE Hedge Fund Activity: Q2 2014 in Review
175 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q2 2014, worth a combined $1.95B — up 9.2% from $1.78B a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of HAE and 22 opened new positions — a net loss of 17 holders — while 64 trimmed existing stakes and 67 added.
The largest buyer was Westwood Holdings Group, opening a new position worth an estimated $45M. The largest seller was Champlain Investment Partners, exiting entirely with an estimated $37.1M sold.
- 175 institutional investors held Haemonetics (HAE) as of Q2 2014, down from 192 in Q1 2014.
- Funds reported $1.95B of Haemonetics stock for Q2 2014, up 9.2% quarter-over-quarter.
- 22 funds opened new Haemonetics positions in Q2 2014 and 39 closed out, a net change of -17 holders.
- The largest Haemonetics buyer in Q2 2014 was Westwood Holdings Group, an estimated $45M added.
- The largest Haemonetics seller in Q2 2014 was Champlain Investment Partners, an estimated $37.1M sold.
Based on aggregated 13F filings for Q2 2014.